国际眼科纵览
• 综述 • 上一篇 下一篇
王婧 朱豫
收稿日期:
出版日期:
发布日期:
通讯作者:
基金资助:
河南省基础与前沿技术研究计划项目 (122300410037)
WANG Jing, ZHU Yu
Received:
Online:
Published:
Contact:
Supported by:
Fundation and Frontier Technology Research Project of Henan Province (122300410037)
摘要:
泪腺上皮性肿瘤中常见的良、恶性肿瘤分别是泪腺多形性腺瘤和腺样囊性癌。泪腺多形性腺瘤易复发、恶变,腺样囊性癌单纯手术疗效不满意,易复发,预后差。分子生物学研究发现,癌基因PLAG1和HMGA2对多形性腺瘤的诊断有较高的敏感性和特异性;MYB基因表达可作为腺样囊性癌的分子诊断指标;抑癌基因INK4a-ARF、信号通路白介素-6(interleukin-6, IL-6)/JAK/STAT3和Notch、基质金属蛋白酶和环氧合酶-2等,在泪腺上皮性肿瘤发生发展、复发、恶变、转移中均有一定作用。
Abstract:
Epithelial tumor of lacrimal gland is a common orbital tumor, and the common benign and malignant tumors are respectively lacrimal pleomorphic adenoma and adenoid cystic carcinoma. Lacrimal pleomorphic adenoma is prone to relapse, malignant change, adenoid cystic carcinoma is not satisfactory to operate simply, easy to relapse, and poor prognosis. In recent years, molecular biology studies have found that oncogene PLAG1 and HMGA2 have high sensitivity and specificity in the diagnosis of pleomorphic adenoma. MYB gene expression can be used as the molecular diagnostic index of adenoid cystic carcinoma. Tumor-suppressor genes INK4a - ARF, signaling pathways, such as IL-6 / JAK/STAT3 and Notch, matrix metalloproteinases (MMP) and cyclooxygenase 2 (COX-2) and so on, have some effect on the development, recurrence, metastasis and transformation of the epithelial tumor of lacrimal gland.
王婧 朱豫. 泪腺上皮性肿瘤分子生物学进展[J]. 国际眼科纵览, doi: 10.3760/ cma.j.issn.1673-5803.2018.04.012.
WANG Jing, ZHU Yu. Molecular biology of lacrimal gland epithelial tumor[J]. International Review of Ophthalmology, doi: 10.3760/ cma.j.issn.1673-5803.2018.04.012.
0 / / 推荐
导出引用管理器 EndNote|Ris|BibTeX
链接本文: http://www.j-bio.net/CN/10.3760/ cma.j.issn.1673-5803.2018.04.012
http://www.j-bio.net/CN/Y2018/V42/I4/269